Stock Screener App

Frei -

Installieren

3.02

0.98% -0.03

Niagen Bioscience Inc (NAGE)

Überblick Nachrichten Preisverlauf Forum Prognose

Niagen Bioscience Inc Aktie (NAGE) Neueste Nachrichten

Niagen Bioscience at canaccord growth conference: cash, science and growth By Investing.com - Investing.com India

Niagen Bioscience, Inc. (NASDAQ: NAGE) Share Price, NAGE Stock News, NAGE Share Price & Updates - Kalkine

HC Wainwright Forecasts Lower Earnings for Niagen Bioscience - MarketBeat

Niagen Bioscience, Inc. (NAGE) Stock Analysis: A 297% Upside Potential Awaits Investor Attention - DirectorsTalk Interviews

Niagen Bioscience launches Tru Niagen on Walmart.com - Investing.com India

HC Wainwright Predicts Weaker Earnings for Niagen Bioscience - MarketBeat

Niagen Bioscience Launches Tru Niagen on Walmart.com, Expanding Access and Diversifying Its E-commerce Marketplace Presence - Yahoo Finance

NAGE Stock Price and Chart — NASDAQ:NAGE - TradingView

Sei Investments Co. Increases Holdings in Niagen Bioscience, Inc. $NAGE - marketbeat.com

Niagen Bioscience, Inc. $NAGE Holdings Boosted by Renaissance Technologies LLC - MarketBeat

Niagen Bioscience (NAGE) On New Aging Study And The Case For A Higher Fair Value - Yahoo Finance

Niagen Bioscience (NAGE) Stock Sinks As Profit Cushion Thins - simplywall.st

Q2 2026 Niagen Bioscience Inc Earnings Call Transcript - GuruFocus

CCORF Maintains Niagen Bioscience(NAGE.US) With Buy Rating, Maintains Target Price $10 - Moomoo

Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Niagen Bioscience Inc (NAGE) (Q2 2026) Earnings Call Highlights: - GuruFocus

Niagen Bioscience, Inc. Stock 12‑Month Price Target Cut to $12.08, Implies 248% Upside - TradingView

Earnings call transcript: Niagen Bioscience posts q2 2026 growth, lifts spending - Investing.com

Niagen Bioscience (NASDAQ:NAGE) Announces Quarterly Earnings Results, Meets Expectations - MarketBeat

Is Niagen Bioscience Inc (NAGE) Undervalued After Q2 Earnings Mi - GuruFocus

Niagen Bioscience (NAGE) Meets Q2 Earnings Estimates - Yahoo Finance

Niagen Bioscience, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:NAGE) 2026-08-04 - Seeking Alpha

Niagen Bioscience Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Niagen Bioscience: Q2 Earnings Snapshot - Barchart.com

Niagen Bioscience, Inc. (NAGE) Q2 FY2026 earnings call transcript - Yahoo Finance

Niagen Bioscience 2026: Revenue $29.79M, EPS $0.01— 10-Q Summary - TradingView

Press Release: Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results - 富途牛牛

[10-Q] Niagen Bioscience, Inc. Quarterly Earnings Report - Stock Titan

Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results - Yahoo Finance

Niagen Bioscience (NAGE) Earnings Date and Reports 2026 - marketbeat.com

Niagen Bioscience selects Evotec for rare disease drug studies - Investing.com

Niagen Bioscience selects Evotec for rare disease drug studies By Investing.com - Investing.com Nigeria

Arrowstreet Capital Limited Partnership Buys 761,685 Shares of Niagen Bioscience, Inc. $NAGE - marketbeat.com

Niagen Bioscience, Inc. (OCD1) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks

Niagen Bioscience, Inc. (NAGE): Investor Outlook Highlights Potential 274% Upside - DirectorsTalk Interviews

Niagen Bioscience Inc expected to post earnings of 2 cents a shareEarnings Preview - TradingView

Niagen Bioscience, Inc. Revenue Breakdown – DUS:OCD1 - TradingView

Niagen Bioscience reports study on muscle aging markers By Investing.com - Investing.com Canada

Niagen Bioscience Announces a Newly Published Analysis of Past Clinical Studies Demonstrating Niagen - Business Wire

Niagen Bioscience reports study on muscle aging markers - Investing.com

Niagen Bioscience Inc (NAGE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference - Caledonian Record

NAGE|Niagen Bioscience Inc|Price:3.240|Chg%:+0.030 - TradingKey

Niagen Bioscience Inc (NAGE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Niagen Bioscience Inc (NAGE) Cash Flow - tradingkey.com

Niagen Bioscience Inc (NAGE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Niagen Bioscience Inc (NAGE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Niagen Bioscience, Inc. Revenue Breakdown – MUN:OCD1 - TradingView

Niagen Bioscience, Inc. Revenue Breakdown – TRADEGATE:OCD1 - TradingView

Niagen Bioscience Inc|Price:3.210|Chg%:+0.020 - TradingKey

Niagen Bioscience, Inc. (NAGE) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks

Niagen Bioscience, Inc. (NAGE) Q3 2023 Earnings ReportResults, Call & Slides - TipRanks

Niagen Bioscience (NAGE) to Announce Q2 Financial Results on Aug - GuruFocus

Niagen Bioscience, Inc. (NAGE) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks

Niagen Bioscience, Inc. (NAGE) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks

Niagen Bioscience, Inc. (NAGE) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks

Niagen Bioscience (NAGE) to Announce Q2 Financial Results on August 4, 2026 - GuruFocus

Press Release: Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026 - Moomoo

Niagen Bioscience to report Q2 2026 results on August 4 - scanx.trade

Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026 - Business Wire

SteelPeak Wealth LLC Makes New Investment in Niagen Bioscience, Inc. $NAGE - MarketBeat

Niagen Bioscience appoints Abhijit Kale as research director By Investing.com - Investing.com Nigeria

MRNA

$63.32

0.52%

RPRX

$58.60

0.07%

ROIV

$36.20

0.22%

INSM

$123.74

2.05%

ALNY

$228.65

0.67%

ONC

$347.48

2.40%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters